多发性硬化
随机对照试验
医学
认知行为疗法
认知
物理疗法
失眠症
协议(科学)
认知疗法
物理医学与康复
失眠的认知行为疗法
临床试验
临床心理学
梅德林
精神科
行为疗法
试点试验
作者
Catherine F Siengsukon,Jade Robichaud,Eryen Nelson,Allison Glaser,Garrett Baber,Matthew Gratton,Anna Zanotto,Milind A. Phadnis,SHARON G. LYNCH
标识
DOI:10.1016/j.conctc.2026.101595
摘要
Insomnia is a common problem for individuals with multiple sclerosis (MS) occurring in at least 40 % of individuals with MS. Sleep disturbances in people with MS have been associated with a reduction in cognitive performance, physical function, psychological well-being, quality of life, and occupational function, as well as increased prevalence of fatigue, pain, depression, and anxiety. Cognitive behavioral therapy for insomnia (CBT-I), a multicomponent treatment strategy, addresses thoughts and behaviors that can negatively impact sleep and is the recommended treatment for chronic insomnia. CBT-I is shown to be more effective than pharmacological interventions long-term for treating insomnia with improvements remaining up to 10 years following CBT-I. However, there are limited studies that have examined the effect of CBT-I on sleep outcomes and comorbid symptoms in people with MS. The objective of the proposed study is to determine the efficacy of CBT-I delivered via telehealth to improve insomnia symptoms, fatigue, and health-related quality of life in people with MS. CBT-I offers a low-risk, cost-effective, non-pharmacological approach to improving sleep quality, fatigue, and daily functioning in individuals with MS. Targeting insomnia in MS may also reduce disability, enhance quality of life, increase employment rates, and lower healthcare and support costs. Furthermore, understanding factors that impact improvement in outcomes will allow more accurate individualization of insomnia treatment for people with MS. Trial registration: The CALM study is registered at: https://clinicaltrials.gov (NCT06428006).
科研通智能强力驱动
Strongly Powered by AbleSci AI